Rosacea in the United States, 2014 to 2024: Market Valuations & Forecasts, Pipeline Products, Epidemiology, Key Products Marketed, Drugs Sales & Market Shares, Competitive Landscape - ResearchAndMarkets.com

DUBLIN--()--The "US Rosacea Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

This latest research provides comprehensive insights into Rosacea pipeline products, Rosacea epidemiology, Rosacea market valuations and forecast, Rosacea drugs sales and competitive landscape in the US.

The research is classified into seven sections - Rosacea treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

  • Rosacea pipeline: Find out the products in clinical trials for the treatment of Rosacea by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Rosacea epidemiology: Find out the number of patients diagnosed (prevalence) with Rosacea in the US
  • Rosacea drugs: Identify key products marketed and prescribed for Rosacea in the US, including trade name, molecule name, and company
  • Rosacea drugs sales: Find out the sales revenues of Rosacea drugs in the US
  • Rosacea market valuations: Find out the market size for Rosacea drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
  • Rosacea drugs market share: Find out the market shares for key Rosacea drugs in the US

Benefits of this Research

  • Support monitoring and reporting national Rosacea market analysis and sales trends
  • Track competitor drugs sales and market share in the US Rosacea market
  • Track competitive developments in Rosacea market and present key issues and learnings
  • Synthesize insights for Rosacea market and products to drive business performance
  • Answer key business questions about the Rosacea market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Rosacea products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered

1) Rosacea Treatments

2) Rosacea Pipeline

3) US Rosacea Epidemiology

4) Marketed Drugs for Rosacea in US

5) US Rosacea Market Size and Forecast

6) US Rosacea Products Sales and Forecast

7) US Rosacea Market Competitive Landscape

8) Methodology

List of Tables

1. Rosacea Phase 3 Clinical Trials, 2019

2. Rosacea Phase 2 Clinical Trials, 2019

3. Rosacea Phase 1 Clinical Trials, 2019

4. Rosacea Epidemiology, US, 2014 - 2024

5. Marketed Drugs for Rosacea, US, 2018

6. Rosacea Market Size and Forecast ($), US, 2014 - 2024

7. Rosacea Product Sales ($), US, 2014 - 2024

List of Figures

1. Rosacea Epidemiology, US, 2014 - 2024

2. Rosacea Market Size and Forecast ($), US, 2014 - 2024

3. Rosacea Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/unt2hy

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Dermatological Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Dermatological Drugs